Inami, M <br/><br/>
Polycythemia associated with the JAK2V617F mutation emerged during treatment of chronic myelogenous leukemia.  [electronic resource] 

 -  Leukemia  May 2007 
 - 1103-4 p.  digital 
<br/><br/> Publication Type: Case Reports; Letter 
<br/><br/><label>ISSN: </label>0887-6924 
<br/><br/><label>Standard No.: </label>10.1038/sj.leu.2404591  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antineoplastic Agents--therapeutic use<br/>Benzamides<br/>Humans<br/>Imatinib Mesylate<br/>Janus Kinase 2--genetics<br/>Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy<br/>Male<br/>Mutation<br/>Piperazines--therapeutic use<br/>Polycythemia--etiology<br/>Pyrimidines--therapeutic use